Dabrafenib 50mg
Dabrafenib is a potent and selective inhibitor of B-RAF protein kinase carrying V600E mutation, currently in clinical trial.
| Trivial name | Dabrafenib 50mg |
| Catalog Number | A11381-50 |
| Alternative Name(s) | N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide |
| Molecular Formula | C23H20F3N5O2S2 |
| CAS# | 1195765-45-7 |
| SMILES | CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F |
| Size | 50mg |
| Supplier Page | http://www.adooq.com/dabrafenib-gsk2118436a.html |